Stock Events

Stock Events

Dare Bioscience 

$0.7350
84
-$0.00-0.5% Friday 20:00
-$0.01-2.03%Friday 23:58After hours

Statistics

Day High
0.7471
Day Low
0.7383
52W High
3.78
52W Low
0.72
Volume
7,058
Avg. Volume
-
Mkt Cap
14.24M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.69
-0.5
-0.32
-0.14
Expected EPS
-0.14
Actual EPS
N/A

Financials

-1,300.87%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.03MRevenue
-13.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DARE. It's not an investment recommendation.
Microsoft
12
MSFT
Tesla
11
TSLA
Amazon
11
AMZN
Dogecoin
11
DOGE.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evofem Biosciences
EVFM
Mkt Cap1.19M
Evofem Biosciences focuses on women's sexual and reproductive health, directly competing with Dare's product offerings.
Pfizer
PFE
Mkt Cap159.99B
Pfizer offers a broad range of products in women's health, including contraceptives and therapies that overlap with Dare's portfolio.
Merck
MRK
Mkt Cap376.37B
Merck, known for its women's health products, competes in the same space as Dare, especially in the contraceptive and fertility sector.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap43.51B
Teva Pharmaceutical has a significant presence in generic women's health products, competing with Dare's offerings.
AMGEN
AMGN
Mkt Cap237.52B
Amgen, through its acquisition of Otezla, competes in the broader women's health and reproductive market.
Novo Nordisk
NVO
Mkt Cap206.69B
Novo Nordisk, with its focus on hormone replacement therapies, shares a competitive space with Dare Bioscience.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie, through its acquisition of Allergan, has expanded its women's health portfolio, making it a competitor to Dare.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson offers a wide range of products in women's health, including contraceptives and gynecological treatments.
Lilly(Eli) &
LLY
Mkt Cap1.12T
Eli Lilly, with its focus on endocrine and women's health, competes in similar therapeutic areas as Dare Bioscience.

About

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Show more...
CEO
Sabrina Martucci Johnson
Employees
24
Country
United States
ISIN
US23666P2002

Listings

STU
DE
1221.STU
XNAS
US
DARE
BOATS
BOATS
DARE.BOATS

0 Comments

Share your thoughts

FAQ

What is Dare Bioscience stock price today?▼
The current price of DARE is $0.74 USD — it has decreased by -0.5% in the past 24 hours. Watch Dare Bioscience stock price performance more closely on the chart.
What is Dare Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Dare Bioscience stocks are traded under the ticker DARE.
Is Dare Bioscience stock price growing?▼
DARE stock has fallen by -10.35% compared to the previous week, the month change is a -36.64% fall, over the last year Dare Bioscience has showed a -63.61% decrease.
What is Dare Bioscience market cap?▼
Today Dare Bioscience has the market capitalization of 14.24M
When is the next Dare Bioscience earnings date?▼
Dare Bioscience is going to release the next earnings report on November 05, 2026.
What were Dare Bioscience earnings last quarter?▼
DARE earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.3 USD resulting in a +32.58% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dare Bioscience revenue for the last year?▼
Dare Bioscience revenue for the last year amounts to 1.03M USD.
What is Dare Bioscience net income for the last year?▼
DARE net income for the last year is -13.4M USD.
How many employees does Dare Bioscience have?▼
As of August 29, 2026, the company has 24 employees.
In which sector is Dare Bioscience located?▼
Dare Bioscience operates in the Health & Wellness sector.
When did Dare Bioscience complete a stock split?▼
The last stock split for Dare Bioscience was on July 01, 2024 with a ratio of 1:12.
Where is Dare Bioscience headquartered?▼
Dare Bioscience is headquartered in SAN DIEGO, United States.